Logo image of STAY

Extended Stay America Inc (STAY) Stock Fundamental Analysis

NASDAQ:STAY - Nasdaq -

20.46  0 (0%)

After market: 20.46 0 (0%)

Fundamental Rating

1

Taking everything into account, STAY scores 1 out of 10 in our fundamental rating. STAY was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of STAY have multiple concerns. STAY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

STAY had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 0.51%
ROE 1.82%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 19.7%
PM (TTM) 1.99%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

There is no outstanding debt for STAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

STAY has an Altman-Z score of 0.84. This is a bad value and indicates that STAY is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 1.79 is on the high side and indicates that STAY has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.46 indicates that STAY may have some problems paying its short term obligations.
STAY has a Quick Ratio of 0.46. This is a bad value and indicates that STAY is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46

3

3. Growth

3.1 Past

STAY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.30%.
The earnings per share for STAY have been decreasing by -16.92% on average. This is quite bad
STAY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.19%.
Measured over the past years, STAY shows a decrease in Revenue. The Revenue has been decreasing by -4.10% on average per year.
EPS 1Y (TTM)-59.3%
EPS 3Y-27.57%
EPS 5Y-16.92%
EPS Q2Q%-42.86%
Revenue 1Y (TTM)-14.19%
Revenue growth 3Y-6.68%
Revenue growth 5Y-4.1%
Sales Q2Q%-2.53%

3.2 Future

Based on estimates for the next years, STAY will show a very strong growth in Earnings Per Share. The EPS will grow by 35.49% on average per year.
The Revenue is expected to grow by 5.70% on average over the next years.
EPS Next Y61.05%
EPS Next 2Y46.61%
EPS Next 3Y39.9%
EPS Next 5Y35.49%
Revenue Next Year12%
Revenue Next 2Y8.4%
Revenue Next 3Y6.99%
Revenue Next 5Y5.7%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
STAY Yearly Revenue VS EstimatesSTAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
STAY Yearly EPS VS EstimatesSTAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 58.46, which means the current valuation is very expensive for STAY.
When comparing the Price/Earnings ratio of STAY to the average of the S&P500 Index (27.50), we can say STAY is valued expensively.
STAY is valuated quite expensively with a Price/Forward Earnings ratio of 25.05.
STAY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 58.46
Fwd PE 25.05
STAY Price Earnings VS Forward Price EarningsSTAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.42
STAY Per share dataSTAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

STAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as STAY's earnings are expected to grow with 39.90% in the coming years.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y46.61%
EPS Next 3Y39.9%

2

5. Dividend

5.1 Amount

STAY has a Yearly Dividend Yield of 1.76%.
STAY's Dividend Yield is slightly below the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.76%

5.2 History

The dividend of STAY decreases each year by -9.61%.
STAY has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-9.61%
Div Incr YearsN/A
Div Non Decr YearsN/A
STAY Yearly Dividends per shareSTAY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2Y46.61%
EPS Next 3Y39.9%

Extended Stay America Inc

NASDAQ:STAY (6/15/2021, 8:00:00 PM)

After market: 20.46 0 (0%)

20.46

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners1.77%
Ins Owner Change0%
Market Cap3.74B
Analysts56.6
Price Target20.78 (1.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.76%
Yearly Dividend0.36
Dividend Growth(5Y)-9.61%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 58.46
Fwd PE 25.05
P/S 3.61
P/FCF N/A
P/OCF N/A
P/B 3.3
P/tB N/A
EV/EBITDA 14.42
EPS(TTM)0.35
EY1.71%
EPS(NY)0.82
Fwd EY3.99%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.66
BVpS6.21
TBVpSN/A
PEG (NY)0.96
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.51%
ROE 1.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 19.7%
PM (TTM) 1.99%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.46
Altman-Z 0.84
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.3%
EPS 3Y-27.57%
EPS 5Y-16.92%
EPS Q2Q%-42.86%
EPS Next Y61.05%
EPS Next 2Y46.61%
EPS Next 3Y39.9%
EPS Next 5Y35.49%
Revenue 1Y (TTM)-14.19%
Revenue growth 3Y-6.68%
Revenue growth 5Y-4.1%
Sales Q2Q%-2.53%
Revenue Next Year12%
Revenue Next 2Y8.4%
Revenue Next 3Y6.99%
Revenue Next 5Y5.7%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A